Cabaletta Bio, Inc. (CABA) Tops Q2 EPS by 8c

Cabaletta Bio, Inc. (NASDAQ: CABA) reported Q2 EPS of ($0.45), $0.08 better than the analyst estimate of ($0.53).

For earnings history and earnings-related data on Cabaletta Bio, Inc. (CABA) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Goldman reinstates Estee Lauder rating, sees turnaround driving growth and margins
• Primoris cuts 2026 outlook on renewables cost overruns, COO exits